Full Transcript Introduction to the Anti-Aging Summit and Dr. Locke 0:07 Hi everyone. 0:08 I'm Doctor Sanjeev Goyal 0:09 and you'll be listening to the advanced Anti-Aging and Technology Summit. 0:12 Today I'll be interviewing Doctor Gordon Locke. 0:16 Gordon Locke is a professor of biochemistry 0:18 and molecular biology at the University of Zagreb. 0:22 Director of the National Science Center of Scientific Excellence 0:25 and Personalized Health Care. 0:27 Honorary professor at the University of Edinburgh and the King's College London. 0:31 And member of the John Hopkins Society of Scholars. 0:34 In 2017 he initiated the launch of the Human 0:37 Glycogen Project and is one of its two co-directors. 0:41 His research team is pioneering high throughput Glycolic analysis 0:45 and an application of glycan biomarkers in the field of precision medicine 0:51 by by combining glycolic data with extensive genetic, epigenetic, 0:55 biochemical and physiological data in a systems biology approach. 0:59 They are trying to understand the role of glycans 1:02 in normal physiology and disease. 1:05 Professor Logue has collected over 200 research articles 1:09 that are cited over 5000 times in 2007. 1:13 He founded Genos, a biotech company that is currently a global leader 1:17 in high throughput light comix research, and Gino's letter 1:21 led to the development of the glycogen test of biological age. 1:27 I hope you enjoyed today's talk with Doctor Locke. 1:30 Okay. Welcome, Doctor Gordon. Love. 1:31 I really appreciate your time. 1:33 Today, to talk about this whole new,
Why Glycans Matter in Biology and Medicine 1:36 you know, whole new field of, glycan comics. 1:40 I'm not sure what the word is, but, thank you, thank you, 1:43 thank you for taking the time all the way from Zagreb. 1:46 So thank you for the invitation. 1:48 It's a pleasure to join you and talk about glycans, because, yes, 1:54 I think glycans are something which is very important. 1:57 I work in the field for nearly 30 years 2:00 now, so I'm kind of a dinosaur of the field, 2:03 but unfortunately not so many people know about it 2:06 because it's not being, the, 2:10 presented in, high schools, not even at university level. 2:14 Very few physicians have heard about glycans 2:19 and practically every protein 2:22 which has been invented after we became multicellular organisms is glycosylated. 2:27 And glycans play an important role in many physiological processes. 2:32 Practically, virtually everything which is above 2:35 the level of a single cell involves some part of the glycans. 2:39 So, we have to learn more about them, and we have to start using this knowledge. 2:45 Right. 2:46 So maybe to take us back, 2:47 how did you even get come up across this whole field like 30 years ago? 2:52 Like, how did you decide this was. 2:53 This was an interesting thing and had such a huge impact. 2:57 But it was a kind of serendipity 3:00 then, because, at one point there was the novel kit to look 3:05 for glycans and my boss at the time was interested for novel things. 3:09 He said, let's try this. 3:10 We tried that and it was interesting. 3:13 And I'm a stubborn guy. 3:14 And I continued going to the direction because we were learning 3:18 more and more and more, and it's becoming more and more interesting. 3:21 And so far we have analyzed over 150,000 3:26 different people from different clinical cohorts, genetic cohorts. 3:30 And we are learning the 3:32 glycans actually 3:35 are big part of inter individual variations. 3:39 So, for example, blood groups are glycans. 3:42 If you think about the A, B and O blood groups, chemically they're like us. 3:47 But there are thousands and hundreds of thousands 3:51 different glycoproteins which all make us different. 3:55 And this is what is very important 3:57 in this field called, precision medicine, 4:01 where we are trying to identify differences between people 4:06 and see why are people different 4:08 and why each of us would respond differently
How Glycan Research Began and Why It Matters 4:12 to the same food, same type of exercise, same drug. 4:16 But people respond differently because they're different. 4:20 That molecular level. 4:21 And one of these differences are glycans. 4:24 You're seeing the biggest inter individual variation is due to glycans. 4:28 Is that right? 4:29 Yes. The huge part of individual variation are glycans. 4:33 And these are these all but they haven't all been mapped out. 4:37 I mean, it sounds like you're saying the 250,000 different glycans. 4:41 No, it's, it's even more complicated. 4:44 So the, the individual glycan blocks are not so complicated. 4:48 There are a couple of thousand of them, 4:50 but they get combined in a many different ways. 4:53 And for example, immunoglobulin antibodies, 4:57 which have a single polypeptide chain, can come in 5:01 over 900 different glycol forms having different glycans attached to it. 5:07 And each of them is a little bit different. 5:09 So it is immense complexity. 5:11 It's several orders of magnitude more complicated than the genes 5:15 and the proteins. 5:17 And this is actually what enabled the life of this planet 5:20 to be so diverse and so complex as it currently is. 5:25 Oh my God, you just I think you just blew my mind. 5:26 You're saying that this is a big. It's like the ocean. 5:28 Like we just discover a whole new field of, metabolic medicine or something. 5:34 Oh, something like a decade ago, I think I wrote the paper with the title 5:39 that Epigenetic Regulation of glycosylation 5:43 is the Quantum Mechanics of Biology. 5:46 So it's it's another layer of complexity because there are two things. 5:50 First, the structural diversity. 5:52 So glycans have many different structures. 5:54 And the second one is, genetic complexity because normally 5:59 each protein is being coded by a single gene. 6:03 So you inherit the gene to have a specific protein. 6:06 But for glycans, they're encoded in a network of dozens 6:11 or even hundreds of genes. 6:13 So you have, a network defining a chemical structure 6:17 which is being inherited as a complex trait. 6:20 But too many genes. 6:22 So it's it's yes, it's entire ocean, entire 6:26 universe of complexity, which are actually like us. 6:30 And we are just learning a tiny little bits of it. 6:33 We, for example, 6:34 one of the proteins which has been studied a lot are immunoglobulins. 6:40 So we know a lot about how antibodies get glycosylated, 6:44 what these, glycans do, how do they make them different. 6:48 And, you know that now many drugs are although 6:52 smart drugs, many of the smart drugs are immunoglobulins. 6:56 So out antibodies are drugs. 6:58 And now their next generation of these drugs 7:01 which are being like engineered. 7:04 So you put a different glycan and then you have a drug 7:08 which is for example 100 times more effective than the original one. 7:12 And the only difference is a tiny little, like an ad at the end of the structure. 7:18 And then you have 100 times more potent drug. 7:21 So it's a whole new field. As you mentioned, whole ocean.
Glycans, Precision Medicine, and Biological Complexity 7:25 So that's so interesting. 7:26 So let's take a step one before we get into the, into the immunoglobulins. 7:30 That so hemoglobin A1 C is this. 7:33 So this is a glycosylated hemoglobin. 7:36 Is that right. 7:37 And so is that a type of glycan marker. 7:40 Is that a type of glycan. 7:43 This this is a common confusion. 7:45 So chemically it is glycosylated because it does 7:49 have a glycan which is chemically bound to a protein. 7:54 But the we call it glycated 7:57 non glycosylated just to make a difference. 7:59 And this process of glycation is a random chemical reaction 8:04 between glucose, which is an aldehyde, and amino groups and a protein. 8:09 So it's a kind of, random. 8:11 It's a chemical reaction which happens when the glucose is elevated. 8:15 So people with diabetes would have a higher level of HbA one C. 8:19 And this, this biomarker is used to measure the the burden of glucose. 8:26 So people who have high glucose will have more HB one C. 8:30 But this is something biologically very different because glycated hemoglobin. 8:35 This is an error which happens when the glucose is high. 8:39 Glycosylation is the enzymatic process regulated by hundreds of enzymes. 8:44 Many transcription factors where the structure 8:47 is designed by evolution. 8:51 So evolution decided which 8:54 glycan structure to have on a specific site 8:57 because it will have a biological function. 8:59 So these two things are actually very different. 9:04 Biologically, functionally 9:07 although strictly chemically, yes. 9:11 Glycated hemoglobin is a glucose attached to to hemoglobin. 9:15 While the glycans I'm talking about are oligosaccharides 9:19 with 10 to 15 different monosaccharides in the different spatial distribution. 9:24 And they actually represent part of the molecule which does the work. 9:28 Wow. Okay. 9:29 So then so I understand. 9:30 So this, this thing about the 9:32 the biomarker for aging, let's, let's move on to that. 9:35 It looks like it's, 9:36 it's a glycan looking at the glycans attached to an immunoglobulin G. 9:40 Is that correct? Yes. 9:42 So so how can you tell me a little bit about. 9:44 Yeah. 9:46 So we are interested to learn 9:49 how people are different in a way they glycosylated proteins. 9:52 And what are the functional consequences. 9:55 And we studied many large 9:58 cohorts, as I said, over 150,000 people so far. 10:02 And what we learned is one of the first finding 10:04 was the glycans change a lot with age. 10:08 So when people are young, 10:10 their immunoglobulins have one type of structures 10:14 which is relatively large, has the galactose and sell it at the end. 10:18 Well, as we are getting older, these structures are becoming 10:23 a little bit smaller. 10:24 They're missing some of these sugars at the end. 10:27 But this is not just kind of wear and tear of glycosylation, 10:31 but it's a reflection of, changes with happened with aging. 10:37 And the main one of the main changes is increasing inflammation. 10:42 Because we are young, we are keeping our inflammation controlled. 10:48 Although actually it's not completely true because when we are kids,
HbA1c vs Glycosylation and the Aging Biomarker 10:52 inflammation can also explode. 10:55 But after puberty and in our early 20s and 30s, 10:59 we keep our inflammation controlled. 11:02 And one of the elements which suppress inflammation are these glycans. 11:07 Globulins. 11:08 So these lichens are actively suppressing inflammation. 11:12 And we I think the best example of this is if there is a therapy 11:16 called IVIg, intravenous immunoglobulins, 11:19 which is being used in some clinical situations. 11:22 If you give immunoglobulins from a young person to an older person, 11:28 you have a systemic suppression of inflammation. 11:31 And this systemic suppression of this low grade chronic inflammation 11:35 is resulting in the phenomenon that these older people 11:39 have a lot of energy, they feel much younger, 11:42 they feel much better because they're not wasting all the energy 11:45 they have on this low grade, chronic inflammation. 11:48 And when we are young, this is happening naturally. 11:52 So our only when the globulins are suppressing inflammation. 11:55 As we are getting older, these old glycans are activating 12:00 some of the molecular mechanisms which lead to inflammation. 12:04 So they're actually promoting inflammation. 12:07 And by promoting inflammation. 12:10 And we are talking about the low grade chronic inflammation 12:12 a little bit of information everywhere. 12:15 And inflammation is a kind of like 12:18 a reset button on a different location than a body. 12:22 Or just like you are resetting 12:23 your computer to just shut everything down and build it again, 12:27 the same thing inflammation does that goes on a specific location. 12:31 Neutrophils kill everything and then everything is being rebuilt, 12:35 which is extremely expensive. 12:36 So we are spending huge amount of our biological energy 12:40 on this low grade chronic inflammation. 12:42 And animal globulins in all people are actually promoting this inflammation. 12:47 And the second thing we learned 12:50 is that this change from young, 12:54 kind of healthy glycans 12:57 to old inflammation promoting glycans 13:00 is not exactly following the trajectory of chronological age. 13:05 Some people move much faster 13:08 into this old glycans, while some people go slowly. 13:13 And this difference between glycan age and the chronological age 13:18 associated with many biomarkers of unhealthy life. 13:23 For example, if you are obese, your glycans are going much faster 13:28 to towards these pro-inflammatory old glycans. 13:32 If you are under too much stress, if you are developing 13:35 many different conditions, this happens also. 13:40 But the interesting thing is that these glycans 13:44 actually change before people become ill. 13:48 For example, we have studied thousands of people with inflammatory 13:51 bowel disease with tried this with different inflammatory conditions, 13:57 and they all have older glycans. 13:59 So young people with rheumatoid arthritis will have glycans of a much older person. 14:05 But these glycans become old 14:07 before the person developed the disease. 14:11 So it is not that the disease is driving the glycans, but the glycans change first. 14:15 And actually they seem to contribute 14:19 to development of disease because they promote inflammation. 14:22 So the idea we have now is not to wait until people get ill, 14:27 because unfortunately, modern medicine functions 14:30 in a way that you go to hospital only when you are sick, 14:35 when you have pain somewhere and something is not working, 14:38 then you go and say, help me, cure me. 14:41 And most of the times these are chronic diseases 14:44 which you cannot cure anymore.
Inflammation, Glycan Age, and Disease Risk 14:46 So people stay, they, we call them chronic because they stay forever. 14:50 So people, 14:52 they just go to diagnosis and then they get therapy for most of their lives. 14:56 And we hope that if you go early 14:59 and you catch this biomarker changing 15:03 before any other symptoms, 15:06 and we know that glycans are not only biomarkers, they're effectors. 15:10 They work toward disease development. 15:13 If you can fix them, if you can repair them on time, 15:18 you will develop a disease much later or not at all. 15:22 And this is why I don't like to talk about 15:26 glycans as a biomarkers of aging. 15:29 They are biomarkers of aging. 15:31 They're actually functional effectors of aging. 15:35 So if if you improve your glycans, 15:38 you're actually slowing down your aging. 15:41 And we did many studies where we can actually 15:46 where we have 15:46 seen that there are ways to improve your likeness. 15:50 So by changing your lifestyle, the diet, losing extra weight, 15:54 you can actually improve your glycans. 15:55 And this is what we are now trying to understand how 16:01 a given person can change their angle icons. 16:05 Because we are not all the same. 16:06 Not everything works for everybody. 16:09 Is there a genetic, some risk factors 16:12 that put people at a higher rate of glycan, aging? 16:16 Like guess there, specific genes? 16:18 Snips or whatever. 16:20 So this is very important question. 16:22 Of course. 16:23 And genetics is an important component. 16:26 And glycans are heritable. 16:29 And heritability is a measure how similar we are to our parents. 16:33 So if something is highly heritable, it's mostly genetic. 16:37 If it is not heritable, it's mostly environmental. 16:40 And glycans are on average 50% 16:43 heritable and 50% environmental. 16:47 But those glycans which change with age are actually even less heritable. 16:52 They're approximately 30% heritable, while 70% is environmental. 16:58 So maybe between one third and one half 17:02 of our glycan composition is defined by our genes. 17:05 So some people just have genes which make their glycans older. 17:10 But even in them, 50% of this, 17:15 variation can be altered by, 17:18 lifestyle, while in other people it's even less so. 17:21 Most of it is lifestyle. 17:23 So yes, genes are important, but genes are something we cannot change. 17:29 And for example, there's I also, 17:32 I'm a professor of molecular biology, so I also teach genetics. 17:36 And I also have a laboratory which is doing genetic analysis. 17:39 And the key problem we have would be the genetic risk factors 17:44 or all the genetic analysis is that you can do a test 17:48 and find that somebody has twice as high 17:51 risk for, diabetes. 17:55 But whatever this person does, 17:58 this risk will always be twice as high because you cannot change your genes. 18:03 While lichens, 18:06 you can actually see the improvement. 18:08 We can also say that, okay, based on glycans 18:11 you have a higher risk to develop some diseases. 18:14 Although, 18:16 we cannot make these claims officially because they are not approved by the FDA. 18:20 But we can say there is a research saying that these things are linked 18:24 and then people can do something to change diet, 18:29 try some kind of, there are many different approaches. 18:33 Maybe we can touch it later, how you can change your glycans, 18:36 and then we can say, yes, you have improved. 18:39 Now your risk is lower and you are way better because you probably know if 18:46 there is a paper a couple of 18:48 maybe a year ago showing very clearly that 18:51 by having a healthy lifestyle, habits, 18:55 you can add up to ten years of healthy life to our lifespan. 19:00 So living healthy gives you ten healthy years, 19:04 but people don't do it. 19:06 And now, if you think about it, if you know that something you do 19:10 will give you extra ten years of healthy life, 19:14 why don't we do it? 19:16 And we don't do it? 19:17 Because the reward comes after several decades. 19:21 You know, I'm not going to suffer today 19:23 to get something after 20 or 30 years. 19:26 The feedback is too long. 19:28 So people, small people get obese, people live unhealthy lifestyle because, 19:32 you know, the the reward or the punishment is so far away that you think about it. 19:38 Well, if 19:40 or now when we have this biomarker which actually tells you, you know, 19:45 you are 35, but your glycans look
Lifestyle, Genetics, and Reversing Glycan Age 19:48 like you are 55 already, 19:51 and then people start to think and they change 19:55 and they see their glycans going down, 19:58 and then they are motivated to continue doing this 20:01 hard thing because, you know, living healthy life is not easy. 20:05 You know, junk food is good. 20:07 People like junk food because, well, it's not good. 20:09 It tastes good, but it's unhealthy. 20:15 Exercise is difficult. 20:18 So people avoid it, but it's healthy. 20:20 And if you do something and you see that it's working, that's great. 20:25 And the other problem we have is, for example, my glycan age is horrible. 20:29 I'm 20 years older than I'm my chronological age. 20:33 And when I learned that a couple of years ago, 20:36 actually 5 or 6 years ago, I try to, you know, kill myself in a gym. 20:42 I was exercising 3 or 4 hours a day. 20:44 I lost ten kilos just by exercising 20:48 and the effect was minimal 20:51 because overtraining is also a bad thing. 20:55 You know, the wear and tear of training too much 20:58 is actually promotion information, 21:01 and you have to find the right way. 21:04 How to exercise. 21:05 You have to find the optimal amount of exercise, type of exercise. 21:09 Even the diet is not working in the same way for everybody. 21:13 We just recently did a study, published it head on over 1000 people 21:17 on five different diets for a year 21:21 and for each given diet, 21:24 there were some people who improved and some who did not. 21:29 So there's no magic diet. 21:30 There's no one diet which works for everybody. 21:33 Some people cope with carbohydrates just fine. 21:36 They can eat carbohydrates. 21:37 Other people have horrible reaction to carbohydrates. 21:42 Some people need a high protein diet. 21:45 Other can't stand it. 21:46 So it's, you know, we are all different. 21:49 And these glycans are a good way to see 21:54 which is working for me and what is not working for me. 21:59 So, what 22:01 what is the mechanism like, let's say, for, exercise to improve glycans 22:06 or weight loss, like how does it actually changing this 22:11 glycan moiety on damiana globulin. 22:14 Like how is that happening. 22:16 So this is something what we are trying to learn now we still don't know much. 22:22 So what we have done, we have done thousands of people 22:26 where we also have a genetic data for them. 22:30 And then we did something which is called 22:32 the Gwas genome wide association studies, 22:36 where we looked for links between genes and glycans. 22:40 And now we have a network of over 40 genes 22:44 which regulate IG like with deletion. 22:46 And now we are dissecting these pathways 22:49 to see which of them is the reacting to which. 22:52 For example, we know that some inflammatory processes 22:56 affect glycosylation like IL six, interleukin 22:59 six, tumor necrosis factor. 23:02 These are all proteins which affect like dilation. 23:05 We also learned that the sample estrogen is very important. 23:09 So hormone levels also heavily affect glycosylation. 23:13 So what we are currently doing in my lab we are trying to take each of these 23:18 pathways, change activity of these genes, look what will happen 23:22 and then try to find a way how to prove it. 23:25 So we still don't know the exact mechanism. 23:29 So the only real, really nice 23:32 designed study we have for these pathways was with the estrogen, 23:37 where we had a randomized, placebo controlled trial. 23:41 And we really showed that they by removing estrogen, by adding estrogen, 23:46 you have this causal link between estrogen and glycosylation. 23:50 For most other things we have only correlative. 23:55 We have association. 23:56 So these things are associate. 23:58 But we cannot guarantee what causal. 24:01 And it's for example also now we are doing many studies in the Covid field. 24:05 And we see that people when they have Covid, 24:08 their glycans drastically change. 24:11 We're just drafting a paper on this topic. 24:14 So it's so there there's a lot of research to be done. 24:17 There's still a lot of things which we don't know, but we are trying 24:21 to learn by by looking by, for example, something we are really interested. 24:26 There's different studies where people change something. 24:32 They start to, go in the diet, they start yoga, 24:37 they start exercising zinc, they start the specific drug. 24:41 For example, we have some data indicating that when people start taking metformin 24:47 like us, improve. 24:49 And so it's there's a lot of research we are doing trying to understand 24:53 how and why this works. 24:56 For the moment, we cannot say upfront. 24:59 We cannot even I haven't sold my like, an agent or like, like energy. Hi. 25:04 So, we still don't have a magic solution, but what we can do, 25:10 we can, 25:13 People can try something, 25:16 and then we can see whether it works for them. 25:18 And for majority of people, it's relatively easy because, 25:24 obesity is a big driver of, this problem. 25:28 From there, I do you like them. 25:29 So, you know, first thing is lose extra kilos 25:32 if you improve on your weight, your glycans will improve. 25:36 And this works for most people. 25:37 But they everybody. 25:38 But for most, it works if people are,
Mechanisms, Hormones, and Intervention Studies 25:43 not obese and have a better glycan age, then it's more difficult. 25:47 Then it's usually either psychological, too much stress and not enough sleep. 25:53 Or it could be. 25:54 It could be overtraining. 25:56 Some people overtrain and then get their glycans, 26:00 because we have a lot of people in different gyms, 26:03 the especially the trainers 26:06 who actually don't look too good because they just exercise too much 26:10 and they usually get very unhappy about it. 26:14 But when you think, you know, when you think about professional athletes, 26:19 we consider them old in their late 30s. 26:23 A professional athlete of 30 something is an old 26:27 football player or whatever. 26:29 And, we still think we are young in our 50s nowadays, 26:33 so it's now too much sport. 26:35 It's not something which is good for your body. 26:38 That's very interesting. 26:39 We had a couple other speakers talk on that exact same same thoughts. 26:44 So do you think that is there any other nutraceuticals? 26:48 I know you mentioned metformin, but your thoughts about, 26:51 you know, you know, potentially adaptogens because these make a difference. 26:55 Could you think, make a difference on glycans? 26:58 Any I, I'm just I mean, 27:00 I'm extremely 27:01 cautious in making any claims in this direction 27:05 because we have done many studies where we have seen 27:09 correlation. 27:11 And then 27:13 we realize it's actually not the effect of, of a drug, 27:18 but it's the fact that the specific group of people 27:22 take a drug or, the moment they start taking something, 27:27 they also change some other habits and then things improve. 27:31 So to be able to claim that something really works, 27:35 we need a proper placebo controlled trials. 27:38 For example, we have a clinic in New York where most of the patients 27:43 going to the clinic are 20 to 40 years younger. 27:47 But I don't know what it is that actually works because they're taking 27:52 many different supplements, hormones, many different things. 27:57 So what we are doing now, we are really trying to dissect this 28:03 and do the placebo 28:04 controlled trials and somehow try to predict 28:09 what will work in a in every specific individual. 28:13 Not not the same things will work for everybody. 28:16 So it's it's still not we have a magic pill 28:19 that will in on sale save all the problems. 28:22 But at least we have a metrics. 28:24 We have a tool to check whether something works or not. 28:29 And then it sounds like, this is like the aging of it sounds like this better. 28:34 The glycan is, increases like a sign of aging of the immune system. 28:40 At least it sounds like something like that. 28:41 Does that mean that something like, you know, 28:45 peptides, like, you know, time is an alpha people are giving is, you know, 28:50 potentially is, to improve and restore 28:52 the immune system or, or this plasmapheresis 28:57 or people are taking the blood out and. 28:58 Yeah, immune system extremely complicated. 29:02 There are so many different branches of the immune system. 29:06 So we usually say that the glycans is aging 29:10 of the immune system, but not entire immune system. 29:14 There are other aspects of the immune system which are not covered. 29:18 And this glycans and immunoglobulins which we measure, 29:21 but definitely it is immune system. 29:24 It is part of the process called inflammation. 29:27 So with as with aging we are in increasing inflammation. 29:31 And then inflammation is driving aging. 29:33 And it's a vicious circle. 29:35 And it's clearly not directly linked to this. 29:40 The oxidative aging DNA damage. 29:43 This is not what we are measuring with glycans. 29:46 It is indeed the organism level at, 29:50 we can call it also part of the immune aging. 29:53 Although I would not claim that entire aspect of immune aging 29:57 was covered with with the glycan on immunoglobulins because now, 30:02 immune system is the most intricate system which we have is 30:07 keeping us alive against all these crazy pathogens that are around. 30:12 How would you 30:13 compare the glycan age, with regard to, you know, compared to epigenetic, 30:18 clock methylation clock, to telomere length measurements? 30:24 So if we talk about epigenetics, 30:26 so definitely epigenetic clock 30:29 is way more accurate for the chronological age 30:33 because the way Steve Horvath 30:36 developed it was that he measured, 30:39 epigenetic marks, these methylation sites on hundreds of thousands of sites, 30:44 and then he collected 300 30:47 and something of them which predict chronological age. 30:50 Well, and actually, his original, aging 30:54 clock is a kind of, not too informative 30:59 because it is too accurate for the gradual age. 31:03 So he now developed this, a grim aging clock and some others.
Comparing Glycans with Epigenetic Clocks and Telomeres 31:08 And there are many other epigenetic clocks now on the market. 31:12 And it's, it's it's a little bit difficult to know exactly which 31:18 part of 31:18 information each of these tests have. 31:22 So, epigenetic tests are interesting. 31:25 The my I always say, you know, for each of these tests. 31:28 So each individual test, 31:30 you know, every company selling a test is selling a different test. 31:33 We have to show what are they actually measuring and what is it predicting. 31:38 And can it be affected by intervention which you know are healthy. 31:43 And unfortunately for most of these test 31:47 it was shown that actually they do not respond to beneficial interventions. 31:51 You know, people, lose weight and the methylation doesn't change that much. 31:56 I think there are only 1 or 2 papers now showing 31:59 effects on methylation. 32:02 I know David Sinclair had some data recently 32:05 where he can actually show that you can improve methylation. 32:08 So I think ventilation is essential piece of information 32:12 linked to aging, but it is still information. 32:17 While the glycans 32:18 glycans are effectors, they're molecules which actually do the work. 32:23 So I think methylation is key. 32:28 I love methylation, we work a lot on epigenetics 32:31 and it is regulating many aspects of of life, 32:35 but it is still just the information. 32:38 It's the data which is sitting somewhere. 32:40 While glycans are molecules 32:44 which, perform function, they suppress inflammation, they promote inflammation. 32:49 So if you improve glycans, you know that you are suppressing inflammation. 32:54 If you change some methylation site, you still do not know 32:57 what is the consequence regarding telomeres? 33:01 Telomeres are very reliable marker 33:05 of cell divisions of a single cell. 33:09 So on a cell level this is the basic mechanism. 33:12 How you prevent a cell of dividing indefinitely. 33:17 You put some kind of a timer. 33:19 You can divide so many times. And you are that. 33:23 But this is on a cellular level. 33:25 We as the trillions of cells 33:28 have very old cells and very young cells. 33:31 And when you look at the telomere length, you can get very different 33:36 telomere length if you take a different part of the same person, 33:40 or if there is something on going on with, with inflammation, 33:46 for example, if there is, not, some kind of, mobilization of, 33:51 of a new cells of the immune system, then the younger cells come in the blood line 33:57 and then you get completely different data than if you do it before. 34:01 So telomeres are great for measuring individual cells. 34:06 And they give you a lot of information about the individual cells 34:09 you are looking at. 34:10 But it's much more difficult to interpret it on the level of an organism. 34:15 So what does it mean if at the moment I have younger 34:19 cells in my blood, is this because I'm younger 34:25 or just something just happened 34:27 and we had to make many new cells because I don't know, cells died 34:31 because of some reason. 34:32 So that's very interesting. I never thought of it that way. 34:34 Are you saying that when they do the leukocyte telomere length, I guess 34:37 they take an average of all the cell telomere length that they tested? 34:42 And so I guess only really depends on what sample they got that day. 34:46 This is the only way you can do it. 34:48 So you take the blood sample and then you measure 34:52 the average length of all the cells in circulation at the moment. 34:55 Because you are not looking 34:56 in the individual cells, you're looking at the full of cells. 35:01 So there are some studies now we just do a single cell telomere length. 35:06 And then you get, you know, 10 or 100,000 pounds per person. 35:10 But it's still you know, it's an average. 35:13 The factor which is affecting the telomeres the most is 35:17 the composition of the cells in your in your blood. 35:21 And they change a lot depending on the inflammatory status on some other aspects. 35:26 So it's as I said, it's 35:29 a very good measure at the cellular level when you're looking at a specific cell, 35:34 but at the level of organism, it's very hard to interpret. 35:39 And also there's very little data that you can actually 35:43 change your telomere length. 35:46 And then again, it's a question whether it's good or bad. 35:49 Because genetically longer telomeres are a risk factor for cancer 35:55 because the 35:55 telomeres are the safety switch against cancer. 35:58 So without telomeres we would have cancers all the time. 36:02 So if you genetically have longer telomeres 36:05 you're actually at higher risk for some type of cancers. 36:09 Really. 36:10 Yeah. 36:11 Because telomeres is a safety switch against cancer. 36:14 So there there was a paper a couple of years ago 36:16 that study hundreds of thousands of people. 36:18 And yes, genetically longer telomeres, 36:22 risk factors for a number of different cancers. 36:26 I thought short telomeres 36:27 also put you at risk of cancer, but I guess that's not true. 36:31 Short telomeres, because that's. 36:33 So there are some examples also where the short telomeres 36:38 a risk for some cancers, are longer for some other cancers. 36:41 It's it's complicated right. Wow. 36:45 So let's come back to the IG glycans. 36:48 So I understand that it's a three month window. 36:50 It gives you a three month window. 36:51 What happened in the last three months like is it is it completely recycling. 36:55 Our IG glycans are recycling completely. 37:00 So it's a little bit 37:01 of the half life of immunoglobulins is approximately three weeks. 37:07 So when we say three months this is the the window 37:10 where we usually see the effect of the intervention. 37:14 So if you decide to do something now it takes some time.
Future Research and the Human Glycan Project 37:19 For example I start losing weight, I lose a few kilos in a month. 37:24 And then this is affecting my glycans. 37:27 And this takes another three or 4 or 5, six weeks. 37:30 So usually the first effects we see after two months, 37:34 after three months, we usually see the effect of intervention. 37:37 Because immunoglobulins live, half life is three weeks. 37:42 So after three weeks orthogonal globulins are gone and the new ones are being made. 37:47 Is there a complete turnover of our glycans every six weeks? 37:51 Like is that is that what's happening like? 37:54 So glycans do not there's no turnover of glycans. 37:58 There's a turnover of human of globulins. 38:00 So entire molecule gets removed and the new molecule is made. 38:04 So it is it's not. 38:06 So it's a half in three weeks and then another half another three weeks. 38:10 Right. 38:11 Vote not just absolutely, but more or less 38:15 after six weeks, there's very little of the original immunoglobulins left. 38:20 Right. 38:22 Okay. 38:22 If somebody has a chronic disease already 38:25 and they reduce their glycans, the glycan age, 38:29 have you seen from the studies any improvement in there. 38:32 And there was, there was a lot of work 38:36 on rheumatoid arthritis. 38:39 And there we do see that 38:42 if you improve your glycans, usually your symptoms decrease. 38:46 For example, since, 38:49 glycans so heavily affected by hormones, 38:53 for example, woman, when they got pregnant, 38:57 their glycans change a lot. 39:00 And also disease usually goes into remission 39:03 while very quickly 39:06 after birth it goes back because the glycans go back 39:09 to this pro-inflammatory stage in the disease, it also comes back. 39:12 So yes, it is possible in some cases we have this data for we don't have 39:19 unfortunately we don't have a drug which can easily improve your glycans. 39:23 So if there would be a drug you take a pill and your glycans improve 39:26 it would be easy to do this type of studies. 39:28 Now most of our studies are just correlative. 39:32 We can look what people have done, what has changed 39:36 and and how would the glycans changed? 39:40 Sounds good. 39:41 So what did you see the next year looking like? 39:44 What are the things that you're looking at in this whole and this whole field of, 39:48 glycans that you mentioned? 39:51 We already analyzed 150,000 people, but these are mostly cross-sectional studies. 39:57 So we have a group of people, 39:58 a and group of people B, and then we look for differences. 40:01 Now we are mostly trying to focus on intervention studies. 40:06 So we have several clinical trials ongoing in different part of Europe 40:10 actually also putting us where 40:13 people do something 40:17 and then we are looking for consequences. 40:19 People start taking different drugs, people lose weight, 40:22 people go and start to meditate. 40:25 People get Covid, people get influenza, 40:29 and we look longitudinally within a person. 40:32 So how the glycans change within the same person with time 40:37 and then try to understand 40:39 what is the cause and what is the consequence. 40:42 The second thing we are doing, we are dissecting this 40:45 glycosylation pathway and trying to identify targets, 40:50 how we could try to change it. 40:52 Because ideally I would like to have a pill, take a pill, 40:57 change your glycans, suppress your inflammation. 41:00 But this this is decades away. 41:03 This is what we are dreaming about. 41:06 Okay. That's awesome. 41:07 So I think, for our viewers, where should they go to learn more? 41:11 I mean, they may see the doctor. 41:13 Doctor, I guess, who's perhaps knows about glycans, but not too many of those. 41:18 How do you what do you suggest? 41:20 So what we are trying to do glycan h, 41:24 company to build also an education site. 41:28 So there is a whole science, part of the website 41:33 where we are trying to communicate this really 41:37 difficult chemical research 41:42 to people to 41:43 try to understand it, because chemically glycans are very complicated. 41:46 But if you try to translate it in, you know, you know, language, 41:50 which is easier for for non-black people, there's a lot of good data there. 41:56 So I think I would start there looking at what we have written already. 42:01 There's also thing called the human glycan project. 42:04 One of the two directors of this project where we are 42:08 coordinating activity of over 300 researchers at the moment, 42:12 where we are trying 42:13 to do something similar, like what the Human Genome Project was, 42:17 where the people around the world 42:20 work together to understand the human genome. 42:23 Now we are trying to understand the human like them. 42:26 So there's also the website of the Human Glycan project, where we also try 42:30 to put all this information and just look for the word glycans. 42:35 It's, it's a, it's a fancy new word which, is bringing a lot of knowledge 42:42 to us. 42:43 And it became very apparent in this Covid pandemic 42:48 that glycans are so important because at the beginning, 42:51 even the director of knowledge was blogging 42:54 about this as glycoprotein without glycans. 42:57 And actually there's more glycans on this S glycoprotein than proteins. 43:02 And very quickly people understand, understood that 43:05 actually glycans play a very important role there. 43:10 And actually glycans are at the frontline 43:13 of this eternal war between us and viruses. 43:17 And we will learn a lot more about glycans because of this pandemic, because now 43:21 everybody realized, wow, a virus can come and it can stop the planet. 43:26 So we have to develop the real weapons, which we need. 43:30 And these are like these mRNA vaccines, the new drugs to fight our real enemy, 43:35 and not just the rockets and the bombers and the thanks to fight other people. 43:40 So I think this 43:41 will become more and more prominent in the future. 43:45 And that like we learned about DNA 43:48 with all these CSI series, they became popular in the 43:53 over 20 years ago. 43:54 Then everybody learns about the DNA with time. 43:57 People also learn about glycans, but it will go slowly. 44:01 It will not go very quickly. 44:02 Yeah, well, thank you so much. 44:04 I mean, this opened up a whole new world for me and I'm sure for the viewers. 44:08 And I'm going to become, getting my glycan test. 44:10 I know it's coming in the mail and I'll be testing myself out as well. 44:13 So thank you so much.
Comments